I Donated My DNA to Help Stop the Coronavirus
By Ronnie S. Stangler,
Medium
| 04. 19. 2020
My personal calculus is that today, collective good trumps individual autonomy.
Last night, I entered intimate personal health information into a database that can be accessed by anyone. This is not a decision that I made lightly. I shared my information with the Personal Genome Project(PGP) at Harvard Medical School. Founded in 2005 by Dr. George Church, the PGP represents an ideal, a vision of effecting ultimate progress in DNA science through the generosity of participants willing to expose personal data for a greater good. Before Covid-19, the PGP used this data for open-source research projects to further our understanding of human genetics, biology, and health. The PGP will now singularly focus on Covid-19, studying both those who have the disease and those who don’t.
Their strategy is uniquely advantaged, as the PGP has already collected its participants’ DNA. Ideally, all subjects who have agreed to participate in this open-source project have already entered all varieties of medical information, from static measures of height, weight, and blood type to information collected over years through contacts with physicians and medical systems.
The grand scheme is to connect genotypes (obtained through...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...